Ignite Creation Date:
2024-05-06 @ 1:36 PM
Last Modification Date:
2024-10-26 @ 1:16 PM
Study NCT ID:
NCT04067336
Status:
RECRUITING
Last Update Posted:
2024-03-15
First Post:
2019-06-25
Brief Title:
First in Human Study of Ziftomenib in Relapsed or Refractory Acute Myeloid Leukemia
Sponsor:
Kura Oncology Inc
Organization:
Kura Oncology Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-09-12
Start Date Type:
ACTUAL
Primary Completion Date:
2024-09-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-30
Completion Date Type:
ESTIMATED
First Submit Date:
2019-06-25
First Submit QC Date:
August 22 2019
Study First Post Date:
2019-08-26
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-03-13
Last Update Post Date:
2024-03-15
Last Update Post Date Type:
ACTUAL